Take a look around.
News
Press Releases
April 11, 2019
Bayer Announces Results of Sub-group Analysis for Vitrakvi® (larotrectinib) in Patients with NTRK Gene Fusion-Positive Metastatic Non-small Cell Lung Cancer (NSCLC)
Bayer today presented subgroup analysis data of patients with non-small cell lung cancer with neurotrophic receptor tyrosine kinase (NTRK) gene fusion treated with Vitrakvi® (larotrectinib).1...
Learn moreApril 08, 2019
Bayer welcomes science-based discussion with regulators, researchers and the public: More than 100 Bayer-owned glyphosate safety study reports accessible as Monsanto integration continues
Bayer welcomes a science-based discussion with regulators around the globe, the international research community, as well as with consumers on the safety profile of glyphosate. To that end, all...
Learn more
